AMICUS THERAPEUTICS - AMICUS WILL GRANT TEVA LICENSE TO MARKET GENERIC GALAFOLD IN U.S. STARTING JAN 30, 2037, IF APPROVED BY FDA

Reuters · 10/17 11:00

Please log in to view news